- Home
- CNTY vs ETON Comparison
CNTY vs ETON Comparison
Compare CNTY & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTY | ETON |
|---|---|---|
| Founded | 1992 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 1.3B |
| IPO Year | 1996 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CNTY | ETON |
|---|---|---|
| Price | $1.28 | $57.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $3.00 | ★ $39.33 |
| AVG Volume (30 Days) | 65.1K | ★ 538.3K |
| Earning Date | 05-08-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.31 | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | ★ $430,529,000.00 | $79,950,000.00 |
| Revenue This Year | $7.17 | $40.90 |
| Revenue Next Year | $3.28 | $47.23 |
| P/E Ratio | ★ N/A | $816.00 |
| Revenue Growth | 10.82 | ★ 104.94 |
| 52 Week Low | $1.14 | $14.27 |
| 52 Week High | $2.85 | $50.18 |
Technical Indicators
Market Signals| Indicator | CNTY | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 75.33 |
| Support Level | $1.24 | $15.77 |
| Resistance Level | $1.35 | N/A |
| Average True Range (ATR) | 0.05 | 3.00 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 60.00 | 93.01 |
Price Performance
Historical ComparisonAbout CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.